Tekla Healthcare Investors:HQH

    Manage Alerts

    Overview

    As of 7/26/2021

     Share
    Price
    NAVPremium/
    Discount
    Current$25.51$25.99-1.85%
    52 Wk Avg$23.23$25.23-7.98%
    52 Wk High$26.08$28.490.43%
    52 Wk Low$19.43$22.67-15.40%
    Regular Distribution TypeManaged Distribution
    Distribution Rate7.84%
    Distribution Amount$0.5000
    Distribution FrequencyQuarterly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    To achieve long-term capital appreciation by investing at least 80% of its assets in securities of health services and medical technology companies. The Trust may invest up to 20% of its net assets in non-US securities and up to 40% in venture capital or other securities subject to legal or contractual restrictions as to resale.

    Capital Structure

    As of 7/26/2021

    Total Investment Exposure:$1,170.428M
    Total Common Assets:$1,170.428M
    Common Shares Outstanding:45,033,795
    Annual Expense Ratios

    As of 9/30/2020

      Per Common Share
    Management Fees0.93%
    Other Expenses:0.17%
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 1.10%
    Fund Management

    Fund Sponsor
    Hambrecht & Quist

    Portfolio Managers
    Daniel R. Omstead

    Basics
    Category: Equity-Sector Equity
    Ticker: HQH
    NAV Ticker: XHQHX
    Average Daily Volume (shares): 141,743
    Average Daily Volume (USD): $3.279M
    Inception Date: 4/23/1987
    Inception Share Price: $10.00
    Inception NAV: $0.00
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports

    Distributions

    As of 7/26/2021

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 3/31/2021
    -$0.0648
    Annualized Distribution Rate on NAV:
    As of 7/26/2021
    7.70%
    Total Return on NAV (12 months):
    As of 7/26/2021
    15.80%
    Total % Portfolio Effectively Leveraged:
    As of 7/26/2021
    0.00%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 7/26/2021

    PeriodAvg Discount
    6 Month-3.76%
    1 Year-7.98%
    3 Year-9.81%
    5 Year-7.69%
    Z-Score

    As of 7/26/2021

    PeriodZStat
    3 Month0.15
    6 Month0.68
    1 Year1.27
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 6/30/2021
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD12.45%5.87%19.32%13.04%
    202024.92%17.57%5.15%5.71%
    201926.81%23.97%26.64%22.38%
    2018-13.12%-7.75%-12.35%-9.96%
    201716.01%15.87%18.18%12.88%
    2016-22.40%-19.93%17.45%14.67%
    20155.10%8.56%-15.98%-12.75%
    201428.33%33.12%5.16%4.65%
    201368.08%53.67%16.34%17.44%
    201233.40%27.05%12.53%11.75%
    201115.39%11.19%-1.05%0.79%
    201019.19%10.06%20.02%17.83%
    200912.30%12.15%50.36%35.04%
    2008-26.12%-21.94%  
    20079.23%16.80%  
    2006-0.14%2.08%  
    20057.06%8.11%  
    200411.81%7.42%  
    200346.33%23.99%  
    2002-37.59%-35.94%  
    200119.64%1.49%  
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 6/30/2021
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 3/31/2021
    172
    Annual Portfolio Turnover:
    As of 9/30/2020
    52.44%
    Asset Allocation

    As of 3/31/2021 reported by Fund Sponsor

    Top Sectors

    As of 3/31/2021 reported by Fund Sponsor

    Sector%Portfolio
    Defensive (Super Sector)93.43%
    Healthcare93.43%
    Preferred Stock5.07%
    Corporate (Super Sector)5.07%
    Cash Equivalents0.84%
    Cash Equivalents (Super Sector)0.84%
    Financial Services0.16%
    Cyclical (Super Sector)0.16%
    Top Holdings

    As of 3/31/2021 reported by Fund Sponsor

    HoldingValue% Portfolio
    Gilead Sciences Inc$60.72M5.44%
    Illumina Inc$52.66M4.72%
    Amgen Inc$49.77M4.46%
    Vertex Pharmaceuticals Inc$44.72M4.01%
    Moderna Inc$39.29M3.52%
    Horizon Therapeutics PLC$36.43M3.26%
    Biogen Inc$36.11M3.24%
    Regeneron Pharmaceuticals Inc$35.23M3.16%
    Abbott Laboratories$19.91M1.78%
    Seagen Inc Ordinary Shares$18.01M1.61%
    Country Allocation

    As of 3/31/2021 reported by Fund Sponsor

    Country% Portfolio
    United States - Equity89.06%
    China - Equity2.31%
    Switzerland - Equity1.15%
    Canada - Equity0.49%
    Germany - Equity0.46%
    Israel - Equity0.30%
    Netherlands - Equity0.25%
    United Kingdom - Equity0.21%
    Denmark - Equity0.13%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    EWB-1456789PR-Y1220W